Insider filing · ADMA
Adam S Grossman
President and CEO
profile →
ADMA Biologics, Inc.
ADMA · Healthcare · 23 filings in 24 months
ticker →
Adam S Grossman sold $354K of ADMA Biologics (ADMA)
Executed Aug 15 2025, disclosed Aug 15 2025, the same day.
Value, as filed
$354K
21,000 sh across 2 lots
Executed
Aug 15 2025
the trade date, as filed
Disclosed
Aug 15 2025
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
AGAdam S Grossman (President and CEO) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in ADMA Biologics, Inc. (ADMA). The largest single filing was $1.8M of ADMA (147,000 sh across 2 lots, as filed), executed Nov 5.
The name
ADMAHealthcare · ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Adam S Grossman in ADMA
ADMASALE
ADMA Biologics, Inc.
$1.8M147,000 sh across 2 lots
Exec Nov 5
Filed Nov 5 · 9:05 PM ET ADMASALE ADMA Biologics, Inc. $227K
15,000 sh × $15.16
Exec Mar 16
Filed Mar 17 · 5:30 PM ET ADMASALE ADMA Biologics, Inc. $241K
15,000 sh × $16.08
Exec Feb 17
Filed Feb 17 · 5:30 PM ET ADMASALE ADMA Biologics, Inc. $416K
21,000 sh across 2 lots
Exec Dec 15 2025
Filed Dec 16 2025 · 5:30 PM ET ADMASALE ADMA Biologics, Inc. $240K
15,000 sh × $16.00
Exec Nov 19 2025
Filed Nov 21 2025 · 5:30 PM ET ADMASALE ADMA Biologics, Inc. $240K
15,000 sh × $16.00
Exec Oct 24 2025
Filed Oct 24 2025 · 5:30 PM ET ADMASALE ADMA Biologics, Inc. $242K
15,000 sh × $16.13
Exec Sep 15 2025
Filed Sep 16 2025 · 5:30 PM ET ADMASALE ADMA Biologics, Inc. $392K
21,000 sh across 2 lots
Exec Jul 15 2025
Filed Jul 16 2025 · 5:30 PM ET